Telix Pharmaceuticals

OverviewSuggest Edit

Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. Its pipeline includes diagnostic and therapeutic products. The company develops drug candidates for the treatment of renal, prostate, and brain cancer.
TypePublic
Founded2017
HQNorth Melbourne, AU
Websitetelixpharma.com

Latest Updates

Share Price (May 2021)$3.3(+2%)
Cybersecurity ratingBMore

Telix Pharmaceuticals Office Locations

Telix Pharmaceuticals has offices in North Melbourne, Fishers, Etterbeek, Herstal and in 1 other location
North Melbourne, AU (HQ)
401/55 Flemington Rd
Etterbeek, BE
Sint-Michielslaan 47
Herstal, BE
Rue de Hermée 255
Kyoto, JP
25 Chūdōji Nishiderachō, Shimogyō-ku
Fishers, IN, US
12 Municipal Dr #330
Show all (5)

Telix Pharmaceuticals Financials and Metrics

Telix Pharmaceuticals Revenue

Market capitalization (3-May-2021)

831.0m

Closing stock price (3-May-2021)

3.3
Telix Pharmaceuticals's current market capitalization is $831 m.
Show all financial metrics

Telix Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Telix Pharmaceuticals Online and Social Media Presence

Embed Graph

Telix Pharmaceuticals News and Updates

Telix Pharmaceuticals Appoints Mr. Richard Valeix as EMEA President

MELBOURNE, Australia and HERSTAL, Belgium, May 02, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Mr. Richard Valeix has joined the Telix executive leadership team in the role of President, Europe, Middle East and Africa (EMEA).

Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine

MELBOURNE, Australia and BAAR, Switzerland, Nov. 29, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into an agreement with Scintec Diagnostics GmbH (‘Scintec’) to acquire TheraPharm GmbH (‘TheraPharm’), a Swiss-German biotechnolog…

Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market

MELBOURNE, Australia and HONG KONG, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into a strategic licence and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited (‘China Grand Pharma’)…

Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for TLX591-CDx (Kit for the preparation o…

Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging

MELBOURNE, Australia and PALO ALTO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announced it has entered into a strategic collaboration agreement with Palo Alto-based Varian Medical Systems, to evaluate the use of advanced prost…

Telix Pharmaceuticals Frequently Asked Questions

  • When was Telix Pharmaceuticals founded?

    Telix Pharmaceuticals was founded in 2017.

  • Who are Telix Pharmaceuticals competitors?

    Competitors of Telix Pharmaceuticals include ImmunSYS, ImmVira and AstraZeneca.

  • Where is Telix Pharmaceuticals headquarters?

    Telix Pharmaceuticals headquarters is located at 401/55 Flemington Rd, North Melbourne.

  • Where are Telix Pharmaceuticals offices?

    Telix Pharmaceuticals has offices in North Melbourne, Fishers, Etterbeek, Herstal and in 1 other location.

  • How many offices does Telix Pharmaceuticals have?

    Telix Pharmaceuticals has 5 offices.